Skip to content
10-Q

Quarterly Report

SILK ROAD MEDICAL, INC.

0001397702-24-000049

← back to feed
Filed
Aug 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Jul 31, 2024 40.63M sh
Shares Diluted Q2 2024 · Jun 30, 2024 39.62M sh
Shares Diluted Q2 2024 · Jun 30, 2024 39.44M sh
Shares Diluted Q2 2024 · Jun 30, 2023 38.77M sh
Shares Diluted Q2 2024 · Jun 30, 2023 38.65M sh
Capex Q2 2024 · Jun 30, 2024 $1.34M
Capex Q2 2024 · Jun 30, 2023 $721K
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$18.71M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$16.76M
Long Term Debt Q2 2024 · Jun 30, 2024 $76.15M
Long Term Debt Q2 2024 · Dec 31, 2023 $75.63M
Short Term Investments Q2 2024 · Jun 30, 2024 $149.34M
Short Term Investments Q2 2024 · Dec 31, 2023 $161.26M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $22.64M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $20.21M
Stockholders Equity Q2 2024 · Jun 30, 2024 $154.68M
Stockholders Equity Q2 2024 · Dec 31, 2023 $151.15M
Current Liabilities Q2 2024 · Jun 30, 2024 $31.57M
Current Liabilities Q2 2024 · Dec 31, 2023 $30.28M
Total Liabilities Q2 2024 · Jun 30, 2024 $115.12M
Total Liabilities Q2 2024 · Dec 31, 2023 $114.16M
Current Assets Q2 2024 · Jun 30, 2024 $241.02M
Current Assets Q2 2024 · Dec 31, 2023 $240.84M
Total Assets Q2 2024 · Jun 30, 2024 $269.81M
Total Assets Q2 2024 · Dec 31, 2023 $265.31M
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.42
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.78
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.35
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.77
Eps Basic Q2 2024 · Jun 30, 2024 −$0.42
Eps Basic Q2 2024 · Jun 30, 2024 −$0.78
Eps Basic Q2 2024 · Jun 30, 2023 −$0.35
Eps Basic Q2 2024 · Jun 30, 2023 −$0.77
Sga Expense Q2 2024 · Jun 30, 2024 $43.82M
Sga Expense Q2 2024 · Jun 30, 2024 $84.59M
Sga Expense Q2 2024 · Jun 30, 2023 $35.83M
Sga Expense Q2 2024 · Jun 30, 2023 $69.91M
Rd Expense Q2 2024 · Jun 30, 2024 $11.88M
Rd Expense Q2 2024 · Jun 30, 2024 $22.54M
Rd Expense Q2 2024 · Jun 30, 2023 $10.78M
Rd Expense Q2 2024 · Jun 30, 2023 $21.21M
Net Income Q2 2024 · Jun 30, 2024 −$16.6M
Net Income Q2 2024 · Jun 30, 2024 −$30.74M
Net Income Q2 2024 · Jun 30, 2023 −$13.48M
Net Income Q2 2024 · Jun 30, 2023 −$29.94M
Operating Income Q2 2024 · Jun 30, 2024 −$17.2M
Operating Income Q2 2024 · Jun 30, 2024 −$32.13M
Operating Income Q2 2024 · Jun 30, 2023 −$14.32M
Operating Income Q2 2024 · Jun 30, 2023 −$31.23M
Gross Profit Q2 2024 · Jun 30, 2024 $38.51M
Gross Profit Q2 2024 · Jun 30, 2024 $75.01M
Gross Profit Q2 2024 · Jun 30, 2023 $32.29M
Gross Profit Q2 2024 · Jun 30, 2023 $59.9M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $12.74M
Cost Of Revenue Q2 2024 · Jun 30, 2024 $24.72M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $13M
Cost Of Revenue Q2 2024 · Jun 30, 2023 $25.53M
Revenue Q2 2024 · Jun 30, 2024 $51.24M
Revenue Q2 2024 · Jun 30, 2024 $99.73M
Revenue Q2 2024 · Jun 30, 2023 $45.3M
Revenue Q2 2024 · Jun 30, 2023 $85.43M